(Q42939279)

English

The persistence in the liver of residual duck hepatitis B virus covalently closed circular DNA is not dependent upon new viral DNA synthesis

scientific article published on 12 August 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

The persistence in the liver of residual duck hepatitis B virus covalently closed circular DNA is not dependent upon new viral DNA synthesis (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

viral persistence

0 references

Hepatitis B virus

1 reference

based on heuristic

inferred from title

author name string

Georget Y Reaiche

1

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Marc F Le Mire

2

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

William S Mason

3

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Allison R Jilbert

4

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

language of work or name

0 references

publication date

12 August 2010

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

406

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

286-292

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Entecavir therapy combined with DNA vaccination for persistent duck hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.07.013

7 January 2021

Effect of antiviral treatment with entecavir on age- and dose-related outcomes of duck hepatitis B virus infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.07.013

7 January 2021

Occult hepatitis B virus infection and its clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.07.013

7 January 2021

Characterization of age- and dose-related outcomes of duck hepatitis B virus infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.07.013

7 January 2021

Kinetics of duck hepatitis B virus infection following low dose virus inoculation: one virus DNA genome is infectious in neonatal ducks

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.07.013

7 January 2021

DNA index, genome size, and electronic nuclear volume of vertebrates from the Miami Metro Zoo.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.07.013

7 January 2021

Covalently closed circular DNA is the predominant form of duck hepatitis B virus DNA that persists following transient infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.07.013

7 January 2021

The competing roles of virus replication and hepatocyte death rates in the emergence of drug-resistant mutants: theoretical considerations.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.07.013

7 January 2021

PCNA and Ki67 expression in breast carcinoma: correlations with clinical and biological variables

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.07.013

7 January 2021

Transmission of occult hepatitis B virus by transfusion to adult and pediatric recipients in Taiwan

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.07.013

7 January 2021

Intracellular levels of hepatitis B virus DNA and pregenomic RNA in peripheral blood mononuclear cells of chronically infected patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.07.013

7 January 2021

The amount of hepatocyte turnover that occurred during resolution of transient hepadnavirus infections was lower when virus replication was inhibited with entecavir.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.07.013

7 January 2021

Real-time PCR quantitation of hepatitis B virus total DNA and covalently closed circular DNA in peripheral blood mononuclear cells from hepatitis B virus-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.07.013

7 January 2021

Immunosuppression reactivates viral replication long after resolution of woodchuck hepatitis virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.07.013

7 January 2021

Hepatitis B virus persistence after recovery from acute viral hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.07.013

7 January 2021

Persistent occult hepatitis B virus infection: experimental findings and clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.07.013

7 January 2021

Rise in gamma interferon expression during resolution of duck hepatitis B virus infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.07.013

7 January 2021

Occult hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.07.013

7 January 2021

The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.07.013

7 January 2021

Hepatocyte turnover during resolution of a transient hepadnaviral infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.07.013

7 January 2021

Comparison between quantitative hepatitis B surface antigen, hepatitis B e-antigen and hepatitis B virus DNA levels for predicting virological response to pegylated interferon-α-2b therapy in hepatitis B e-antigen-positive chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.07.013

7 January 2021

On the evolution of genome size of birds

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.07.013

7 January 2021

Antiviral therapy and resistance with hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.07.013

7 January 2021

Occult hepatitis B.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.07.013

7 January 2021

Sequence comparison of an Australian duck hepatitis B virus strain with other avian hepadnaviruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.07.013

7 January 2021

Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.07.013

7 January 2021

Peginterferon alpha-2b plus adefovir induce strong cccDNA decline and HBsAg reduction in patients with chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.07.013

7 January 2021

Natural history of chronic hepatitis B virus infection: what we knew in 1981 and what we know in 2005.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.07.013

7 January 2021

Persistent viremia after recovery from self-limited acute hepatitis B

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.07.013

7 January 2021

Woodchuck hepatitis virus infections: very rapid recovery after a prolonged viremia and infection of virtually every hepatocyte

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.07.013

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VIROL.2010.07.013

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42939279&oldid=1974089691"